Exogene
Exogene is a techbio startup leveraging deep learning to discover innovative TCR-based therapies for cancer treatment. By harnessing the natural ability of human T-cells to eliminate diseased cells, Exogene's generative AI platform comprehensively mines the TCR sequence space to identify novel, high-affinity, and non-cross-reactive TCRs against shared cancer targets. This approach addresses the challenge of finding safe and effective TCRs, positioning Exogene as a leader in the development of TCR-based immunotherapies. The company aims to accelerate the discovery process, making it faster and more cost-effective, thereby enhancing its market position in the competitive biotech landscape.
Exogene
Exogene is a techbio startup leveraging deep learning to discover innovative TCR-based therapies for cancer treatment. By harnessing the natural ability of human T-cells to eliminate diseased cells, Exogene's generative AI platform comprehensively mines the TCR sequence space to identify novel, high-affinity, and non-cross-reactive TCRs against shared cancer targets. This approach addresses the challenge of finding safe and effective TCRs, positioning Exogene as a leader in the development of TCR-based immunotherapies. The company aims to accelerate the discovery process, making it faster and more cost-effective, thereby enhancing its market position in the competitive biotech landscape.